PATENT CLAIM ANALYSIS

Application Number: 16175261
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2020-01
Patent Classification: ["424", "001690"]

Abstract:
The present invention relates to radionuclide complex solutions of high concentration and of high chemical stability, that allows their use as drug product for diagnostic and/or therapeutic purposes. The stability of the drug product is achieved by at least one stabilizer against radiolytic degradation. The use of two stabilizers introduced during the manufacturing process at different stages was found to be of particular advantage.

Claim (Index 20):
The pharmaceutical aqueous solution obtained by the process of  claim 1 .

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.30769
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16175239', '15133623', '15133726', '13264276', '10513586']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7253559461480711
- 35 USC 102 Novelty (BERT): 0.5956487827018772
- Combined Prediction Score: 0.7123852298034518
- Mean Citation Score: 269.07739200000003
- Max Citation Score: 542.529
- Similarity Product: 423.9348257583976

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test